Marc Auriacombe1, Sarah Moriceau2, Fuschia Serre2, Cécile Denis3, Jean-Arthur Micoulaud-Franchi4, Etienne de Sevin5, Emilien Bonhomme5, Stéphanie Bioulac4, Mélina Fatseas2, Pierre Philip4. 1. University of Bordeaux, Bordeaux, France; SANPSY, CNRS USR 3413, Bordeaux, France; Pôle Addictologie, CH Charles Perrens and Unité de Soins Complexes d'addictologie (USCA) CHU de Bordeaux, Bordeaux, France; Center for Studies of Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Phildelphia, PA, USA. Electronic address: marc.auriacombe@u-bordeaux.fr. 2. University of Bordeaux, Bordeaux, France; SANPSY, CNRS USR 3413, Bordeaux, France; Pôle Addictologie, CH Charles Perrens and Unité de Soins Complexes d'addictologie (USCA) CHU de Bordeaux, Bordeaux, France. 3. SANPSY, CNRS USR 3413, Bordeaux, France; Center for Studies of Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Phildelphia, PA, USA. 4. University of Bordeaux, Bordeaux, France; SANPSY, CNRS USR 3413, Bordeaux, France; Clinique du sommeil, CHU de Bordeaux, Bordeaux, France. 5. University of Bordeaux, Bordeaux, France; SANPSY, CNRS USR 3413, Bordeaux, France.
Abstract
BACKGROUND: Substance use disorders are under-detected and not systematically diagnosed or screened for by primary care. In this study, we present the acceptability and validity of an Embodied Conversational Agent (ECA) designed to screen tobacco and alcohol use disorder, in individuals who did not seek medical help for these disorders. METHODS: Individuals were included from June 2016 to May 2017 in the Outpatient Sleep Clinic of the University Hospital of Bordeaux. DSM-5 diagnoses of tobacco and alcohol use disorders were assessed by human interviewers. The ECA interview integrated items from the Cigarette Dependence Scale-5 (CDS-5) for tobacco use disorder screening, and the "Cut Down, Annoyed, Guilty, Eye-opener" (CAGE) questionnaire for alcohol use disorder screening. Paper version of CDS-5 and CAGE questionnaires and acceptability questionnaire was also self-administered. RESULTS: Of the 139 participants in the study (mean age 43.0 [SD = 13.7] years), 71 were women, and 68 were men. The ECA was well accepted by the patients. Paper self-administered CDS-5 and CAGE scores had a strong agreement with the ECA (p < 0.0001). The Receiver Operating Characteristic (ROC) analysis of the ECA interview showed AUC of 0.97 (95% CI, 0.93-1.0) and 0.84 (95% CI, 0.69-0.98) for CDS-5 and CAGE respectively with p-value <0.0001. CONCLUSIONS: This ECA was acceptable and valid to screen tobacco or alcohol use disorder among patients not requesting treatment for addiction. The ECA could be used in hospitals and potentially in primary care settings to help clinicians to better screen their patients for alcohol and tobacco use disorders.
BACKGROUND: Substance use disorders are under-detected and not systematically diagnosed or screened for by primary care. In this study, we present the acceptability and validity of an Embodied Conversational Agent (ECA) designed to screen tobacco and alcohol use disorder, in individuals who did not seek medical help for these disorders. METHODS: Individuals were included from June 2016 to May 2017 in the Outpatient Sleep Clinic of the University Hospital of Bordeaux. DSM-5 diagnoses of tobacco and alcohol use disorders were assessed by human interviewers. The ECA interview integrated items from the Cigarette Dependence Scale-5 (CDS-5) for tobacco use disorder screening, and the "Cut Down, Annoyed, Guilty, Eye-opener" (CAGE) questionnaire for alcohol use disorder screening. Paper version of CDS-5 and CAGE questionnaires and acceptability questionnaire was also self-administered. RESULTS: Of the 139 participants in the study (mean age 43.0 [SD = 13.7] years), 71 were women, and 68 were men. The ECA was well accepted by the patients. Paper self-administered CDS-5 and CAGE scores had a strong agreement with the ECA (p < 0.0001). The Receiver Operating Characteristic (ROC) analysis of the ECA interview showed AUC of 0.97 (95% CI, 0.93-1.0) and 0.84 (95% CI, 0.69-0.98) for CDS-5 and CAGE respectively with p-value <0.0001. CONCLUSIONS: This ECA was acceptable and valid to screen tobacco or alcohol use disorder among patients not requesting treatment for addiction. The ECA could be used in hospitals and potentially in primary care settings to help clinicians to better screen their patients for alcohol and tobacco use disorders.
Authors: Zhaopeng Xing; Fei Yu; Jian Du; Jennifer S Walker; Claire B Paulson; Nandita S Mani; Lixin Song Journal: J Med Internet Res Date: 2019-11-18 Impact factor: 5.428
Authors: Alaa A Abd-Alrazaq; Mohannad Alajlani; Nashva Ali; Kerstin Denecke; Bridgette M Bewick; Mowafa Househ Journal: J Med Internet Res Date: 2021-01-13 Impact factor: 5.428
Authors: Amy Rubin; Nicholas A Livingston; Julianne Brady; Elise Hocking; Timothy Bickmore; Molly Sawdy; Nancy Kressin; Richard Saitz; Steven Simon Journal: J Gen Intern Med Date: 2021-06-18 Impact factor: 5.128
Authors: Pierre Philip; Lucile Dupuy; Charles M Morin; Etienne de Sevin; Stéphanie Bioulac; Jacques Taillard; Fuschia Serre; Marc Auriacombe; Jean-Arthur Micoulaud-Franchi Journal: J Med Internet Res Date: 2020-12-18 Impact factor: 7.076
Authors: Marc Auriacombe; Lucie Fournet; Lucile Dupuy; Jean-Arthur Micoulaud-Franchi; Etienne de Sevin; Sarah Moriceau; Emmanuelle Baillet; Jean-Marc Alexandre; Fuschia Serre; Pierre Philip Journal: Front Psychiatry Date: 2021-07-16 Impact factor: 5.435